| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Cai,Shou-Guan | Chairman | 6.41% | |
| Lu,Xian-Qing | Director | 5.99% | |
| Xu,Song-Gang | Director | 2.04% | |
| Ji,Xian-Liang | Director | 1.51% | |
| Wang,Yong-Liang | Independent Director | 0.00% | |
| Chen,Yong-Lai | Independent Director | 0.00% | |
| Xiao,Shu-Zhen | Independent Director | 0.00% |
Change Company Name to GUANGDING BIOTECHNOLOGY CO., LTD. (FORMER NAME: GUANGDING PRECISION TECHNOLOGY CO., LTD.)
2023/07/10
Change Company Name to BIOPTIC INC.
2023/07/10
Change Company Name to GUANGDING BIOTECHNOLOGY CO., LTD. (FORMER NAME: GUANGDING PRECISION TECHNOLOGY CO., LTD.)
2022/09/12
Change Company Name to BIOPTIC INC.
2022/09/12
Change Capital to 500,000,000
2019/07/16
Change Person in Charge to Cai,Shou-Guan
2019/03/26
Change Capital to 200,000,000
2017/02/02
Change Capital to 80,000,000
2012/01/13
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 77,494 | 228,269 | 231,404 |
| Operating cost | 25,062 | 75,524 | 78,758 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 52,432 | 152,745 | 152,646 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 52,432 | 152,745 | 152,646 |
| Operating expenses | 50,767 | 108,692 | 87,716 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 1,665 | 44,053 | 64,930 |
| Non-operating income and expenses | 4,914 | 4,350 | 13,377 |
| Net profit (loss) before tax | 6,579 | 48,403 | 78,307 |
| Income tax expense (benefits) | 1,066 | 8,281 | 14,952 |
| Net profit (loss) of ongoing business for the current period | 5,513 | 40,122 | 63,355 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 5,513 | 40,122 | 63,355 |
| Other comprehensive profit (loss), net | 714 | -471 | 214 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 6,227 | 39,651 | 63,569 |
| Net profit (loss) attributable to owners of parent company | 5,922 | 37,747 | 61,272 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -409 | 2,375 | 2,083 |
| Comprehensive profit (loss) attributable to owners of parent company | 6,336 | 37,474 | 61,413 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -109 | 2,177 | 2,156 |
| Basic earnings per share (yuan) | 0 | 1 | 2 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -8,732 | -12,746 | 69,475 |
| Net cash inflows (outflows) from investing activities | -766 | -159,039 | 2,241 |
| Net cash inflow (outflow) from financing activities | -4,624 | 45,937 | -14,750 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 940 | -761 | 214 |
| Increase (decrease) in cash and cash equivalents in the current period | -13,182 | -126,609 | 57,180 |
| Beginning balance of cash and cash equivalents | 80,606 | 207,215 | 150,035 |
| Ending balance of cash and cash equivalents | 67,424 | 80,606 | 207,215 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 277,591 | 303,540 | 372,582 |
| Non-current asset | 302,049 | 310,233 | 148,862 |
| Total asset | 579,640 | 613,773 | 521,444 |
| Current liability | 46,339 | 77,507 | 83,987 |
| Non-current liability | 89,188 | 93,056 | 10,098 |
| Total liability | 135,527 | 170,563 | 94,085 |
| share capital | 300,806 | 266,200 | 242,000 |
| Equity - secruity token | - | - | - |
| capital reserve | 77,773 | 89,752 | 101,852 |
| retained earning | 53,941 | 75,970 | 74,523 |
| Other equity | 266 | -148 | 125 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 432,786 | 431,774 | 418,500 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 11,327 | 11,436 | 8,859 |
| Total Equity | 444,113 | 443,210 | 427,359 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 16 | 16 | 17 |
